Commentary of the article : IL-2 in combination with IFN-a and 5-FU versus tamoxifen in metastatic renal cell carcinoma : long term results of a controlled randomized clinical trial, by Atzpodien J, Kirchner H, Illiger HJ, Metzner B, Ukena D, Schott H, Funke PJ, Gramatzki M, Jurgenson S, Wandert T, Patzelt T, Reitz M (Br J Cancer 2001 ; 85 : 1130-1136)
Nom du journal : Evidence-based Oncology
Année : 2002
Volume : 3
Page de départ : 92